SCLP — Scancell Holdings Share News
0.000.00%
- £120.85m
- £127.58m
- £5.27m
REG - Scancell Hlds - Signs Commercial License Agreement with Genmab
AnnouncementREG - Scancell Hlds - Change of Nominated Adviser
AnnouncementREG - Scancell Hlds - Holding(s) in Company
AnnouncementREG - Scancell Hlds - Preclinical data at the EuroMAbNet Annual Meeting
AnnouncementREG - Scancell Hlds - Change of Registered Office
AnnouncementREG - Scancell Hlds - First patient dosed in Cohort 2 of the ModiFY
AnnouncementREG - Scancell Hlds - Scancell to produce TCB antibodies
AnnouncementREG - Scancell Hlds - Price Monitoring Extension
AnnouncementREG - Scancell Hlds - Second Price Monitoring Extn
AnnouncementREG - Scancell Hlds - Phase 2 SCOPE trial of SCIB1 vaccine expanded
AnnouncementREG - Scancell Hlds - First patient dosed in Modi-1 Phase 1 trial
AnnouncementREG - Scancell Hlds Barclays Bank PLC - Change of Registered Holder of Shares
AnnouncementREG - Scancell Hlds - Price Monitoring Extension
AnnouncementREG - Scancell Hlds - Second Price Monitoring Extn
AnnouncementREG - Scancell Hlds - Second Price Monitoring Extn
AnnouncementREG - Scancell Hlds - Price Monitoring Extension
AnnouncementREG - Scancell Hlds - Modi-1 Phase 1/2 trial open for recruitment
AnnouncementREG - Scancell Hlds - Update on COVIDITY clinical trial
AnnouncementREG - Scancell Hlds - Scancell progresses its new anti-glycan mAb
Announcement